An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare payer perspective

Abstract Background Three recent randomized controlled trials demonstrated that, in patients with symptomatic paroxysmal atrial fibrillation (PAF), first-line pulmonary vein isolation with cryoballoon catheter ablation reduces atrial arrhythmia recurrence compared to initial antiarrhythmic drug (AAD...

Full description

Saved in:
Bibliographic Details
Main Authors: Malte Kuniss, Lucy Hillcoat, Joe Moss, Florian Straube, Jason Andrade, Oussama Wazni, Gian Battista Chierchia, Lukas Schwegmann, Eleni Ismyrloglou, Alicia Sale, Stuart Mealing, Tom Bromilow, Emily Lane, Damian Lewis, Andreas Goette
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Health Services Research
Subjects:
Ablation
Cryoablation
Cost-effectiveness
Paroxysmal atrial fibrillation
Antiarrhythmic drug
Online Access:https://doi.org/10.1186/s12913-024-11967-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12913-024-11967-0

Similar Items